HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - Changes at JenaValve Technology:

This article was originally published in Clinica

Executive Summary

Germany's JenaValve Technology has established a scientific advisory board, appointing eight members with immediate effect. It is headed by Professor Hans-Reiner Figulla, a cardiologist and co-founder and inventor at the Munich-based minimally-invasive aortic valve replacement systems developer. The other members are: fellow co-founder and inventor Dr Markus Ferrari; stent catheter consultant Dr Younes Boudjemline (Necker Hospital, Paris); Professor Junbo Ge, co-chair of the Shanghai Institute of Cardiovascular Diseases and president of the Shanghai Society of Cardiology; Professor Martin Rothman, director of cardiac R&D at London's Barts hospital; Professor Ziyad Hijazi, of Chicago's Rush University; Professor Jan Gummert, director of cardiothoracic surgery at Friedrich Schiller University Jena, Germany; and Professor Horst Sievert, director of the CardioVascular Center, Frankfurt.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel